Johnson & Johnson Applies for FDA Emergency Use of Covid-19 Vaccine
In some good news, a new coronavirus vaccine is one step closer to getting FDA Emergency Use Authorization! Johnson & Johnson’s global phase 3 clinical trials of their vaccine yielded an 85% efficacy rate for preventing moderate to severe disease. The shot, which was made in partnership with Janssen pharmaceuticals, requires only a single dose and basic refrigeration, making it…